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Highlights (3 à 5 de 125 caractères max avec les espaces) 
 Inhibition of cholinesterase by organophosphate poisoning strongly impacts 
respiration patterns. 
 Long pauses after inspiration are mainly triggered by brain-permeant cholinesterase 
inhibitors. 
 Mutant mice with normal acetylcholinesterase in brain and deficient in muscles do not 
present long pauses post-inspiration after brain-permeant inhibitors exposure. 
 Long pauses after inspiration caused by nasal irritants are reversed by eucalyptol 
acting on afferent sensory neurons, presumably by acting TRPM8 receptor. 
 Long pauses after inspiration triggered by brain permeant cholinesterase inhibitors are 
reversed by eucalyptol. 
 
Abstract 
Respiration failure during exposure by cholinesterase inhibitors has been widely assumed to 
be due to inhibition of cholinesterase in the brain. Using a double chamber plethysmograph to 
measure various respiratory parameters, we observed long “end inspiratory pauses” (EIP) 
during most exposure that depressed breathing. Surprisingly, Colq KO mice that have a 
normal level of acetylcholinesterase (AChE) in the brain but a severe deficit in muscles and 
other peripheral tissues do not pause the breathing by long EIP. In mice, long EIP can be 
triggered by a nasal irritant. Eucalyptol, an agonist of cold receptor (TRPM8) acting on 
afferent sensory neurons and known to reduce the EIP triggered by such irritants, strongly 
reduced the EIP induced by cholinesterase inhibitor. These results suggest that  acetylcholine 
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(ACh) spillover from the neuromuscular junction , which is unchanged in Colq KO mice, may 
activate afferent sensory systems and trigger sensory reflexes, as reversed by eucalyptol. 
Indeed, the role of AChE at the cholinergic synapses is not only to accurately control the 
synaptic transmission but also to prevent the spillover of ACh. In the peripheral tissues, the 
ACh flood induced by cholinesterase inhibition may be very toxic due to interaction with non-
neuronal cells that use ACh at low levels to communicate with afferent sensory neurons. 
 
keywords (max 6) 
acetylcholinesterase; butyrylcholinesterase; organophosphate; respiration; mice; eucalyptol 
 
1 Introduction 
According to the EMA (European Medical Agency) (2003), treating respiratory failure by 
controlled ventilation after intubation is the immediate therapeutic priority after poisoning by 
acute doses of organophosphate compounds (OP) (Stone, 2018a). OP and carbamates 
contribute to pesticide exposure with around 100,000 deaths/year worldwide (Eddleston, 
2019). OP chemical warfare nerve agents, such as sarin, have intoxicated people during the 
Iran-Iraq war (midd-1980) (Stone, 2018a), and in Syria (2013, 2017) (Dolgin, 2013). Indeed, 
even low doses and short exposure to these irreversible inhibitors of acetylcholinesterase 
(AChE) and butyrylcholinesterase (BChE) induced subsequent, well-characterized cholinergic 
syndrome including miosis, seizures, and apnea (Cannard, 2006), and finally death. Thus, 
deaths following acute OP exposure are due to respiratory failure. In addition to this 
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toxidrome, OP affect others system in a time dependent manners, such as neurogenic 
inflammation, immune-neuro interaction and oxidative stress leading to airway 
hyperreactivity (Shaffo et al., 2018). 
The current scientific paradigm explaining the respiratory failure caused by OP poisoning is 
focused nearly exclusively on cholinergic synaptic transmission consequences of these 
chemicals. It is assumed that after cholinesterase (ChE) inhibition the excess of acetylcholine 
(ACh) in the central cholinergic synapses dramatically affects the respiratory centers in the 
central nervous system (CNS) and leads to the respiratory arrest by central apnea (Hulse et al., 
2014; Stone, 2018b). 
However, this paradigm does not fully agree with observations in AChE knockout (KO) mice 
that need special care during the post-natal development (Duysen et al., 2002) but they can 
survive into adulthood, likely because BChE acts as a back-up enzyme for deficient AChE 
(Hartmann et al., 2007). The surviving AChE KO mice are very sensitive to OPs and to 
selective BChE inhibitors as bambuterol (Duysen et al., 2001; Xie et al., 2000): adult and 
neonate AChE KO mice stop breathing following peripheral blockade of BChE. Since this 
selective BChE inhibitor used does not reach BChE in the CNS, and since it does not perturb 
central respiratory activity recorded from spinal nerve rootlets in the brainstem of AChE KO 
mice (Chatonnet et al., 2003), these observations suggest that in AChE KO mice OPs and this 
selective BChE inhibitor act on peripheral ChEs. A plausible target is the neuromuscular 
junction (NMJ) where BChE, is anchored on the terminal Schwann cells and control ACh 
spillover (Petrov et al., 2014). However, in AChE KO mice, BChE inhibitors do not change 
the amplitude of repetitive end plate potential (EPP) triggered by nerve stimulation at 
different frequency (Minic et al., 2003). Thus, the ventilation failure after inhibition of BChE 
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cannot be caused by an acute failure of muscle contraction resulting from the reduction of the 
amplitude of the EPP below a threshold to generate muscle action potential. 
We decided to extend the observations made on AChE KO mice by examining the effects of 
cholinesterase inhibitors (ChEIs) on mice having a partial deficit of AChE. We selected three 
lines: two in which AChE anchoring is deficient (PRiMA KO and Colq KO mice) and one in 
which AChE is not expressed in skeletal muscles (AChE1iRR). PRiMA is the main anchor of 
AChE in the CNS, where it anchors AChE tetramers at the plasma membrane in cholinergic 
neurons (Dobbertin et al., 2009). PRiMA KO mice have practically no AChE in the brain and 
yet adapt remarkably to the resulting excess of ACh in brain ( Farar et al., 2012). They have 
normal AChE level at the NMJ (Bernard et al., 2011) and breathe normally (Boudinot et al., 
2009). Colq protein clusters AChE at the NMJ (Bernard et al., 2011). Colq KO mice present a 
severe growth retardation and muscle weakness (Bernard et al., 2011; Feng et al., 1999). 
Finally, AChE1iRR mice, in which a short deletion in intron 1 prevents the expression of 
AChE in skeletal muscles and in derivative neural crest cells (Bernard et al., 2011; Camp et 
al., 2010), also show muscle weakness but do not have the severe growth retardation of Colq 
KO mice and breathe normally (Boudinot et al., 2009). 
To evaluate the respiratory effects of ChEIs in WT mice and in AChE deficient mice, we 
recorded nasal and thoracic flows separately by double chamber plethysmography (DCP), 
measured respiratory frequency, identified apneic episodes, and measured specific airway 
resistance. To inhibit ChEs we selected sub-lethal doses of paraoxon, an OP pesticide 
metabolite that crosses the blood brain barrier (BBB); physostigmine, a carbamate that 
crosses the BBB; and pyridostigmine, a carbamate that does not cross the BBB. We showed 
that respiratory changes were induced by not only AChE inhibition in the brain but also by the 
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inhibition of peripheral ChEs. In particular, long pauses after inspiration (called end 
inspiratory pauses, EIP), a classical and stereotyped respiratory reflexe to irritant molecules 
exposure, were observed after mice exposure and could not be simply explained by AChE 
inhibition at cholinergic synapses in the brain nor at the NMJ alone. Since the duration of EIP 
observed when mice breathe irritant molecules can be reduced by eucalyptol, we tested the 
effects of this compound on EIP triggered by physostigmine. 
2 Materials and methods 
2.1 Animals 
Adult male and female mice were maintained on a mixed B6D2 genetic background. Before 
beginning any experiment, they were housed for 7 days, in an environment maintained at 23  
0.5°C, 38-41% of humidity, on a 12h dark/light cycle with light provided between 7a.m and 
7p.m. They were given food and water ad libitum. All experiments were carried out in 
compliance with the European Committees Council Directive (86/609/EEC) and were 
approved by Paris Descartes University ethics committee for animal experimentation 
(CEEA34.EK/AGC/LB.111.12). 
Experiments were performed on four strains of mice: (1) Wild type (WT) mice (n=45) were 
picked in the colonies in which Colq KO and AChE1iRR KO mice were maintained as 
heterozygotes, (2) PRiMA KO mice (n=25) have an inactivation of exon 3 encoding the 
domain that interacts with AChE (Dobbertin et al., 2009). (3) Colq KO mice (n=16) have a 
deletion of the exon2 encoding the domain that interacts with AChE (Feng et al., 1999). (4) 
AChE1iRR mice (n=16) have a deletion of an enhanceosome in intron1 of AChE gene which 
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prevent the expression of AChE in skeletal muscles and in cells deriving from the neural crest 
(Camp et al., 2008). 
2.2 Chemicals 
Each compound was injected as 10L of solution per 1g of mouse body weight 
subcutaneously (s.c). The injected solutions were prepared daily. Sub-lethal doses of ChEI 
have been adequately chosen to induce quantifiable respiratory modifications. 
-Saline solution (0.9% NaCl) + dimethyl sulfoxide (DMSO) 1% was used as control (vehicle). 
-Paraoxon was purchased from Sigma-Aldrich® (Saint-Quentin Fallavier, France), CAS 311-
45-5. The solution was stocked at a concentration of 35mg/mL into DMSO at 4°C. The stock 
solution was dissolved at 0.4mg/kg into saline solution. 
-Physostigmine hemisulfate was purchased from Santa Cruz Biotechnology® (Dallas, Texas), 
CAS 64-47-1. The solution was stocked at a concentration of 0.001mol/L into saline solution. 
The stock solution was dissolved at 0.27mg/kg into saline solution. 
-Pyridostigmine bromide (3-dimethylaminocarbonyloxy-N-methylpyridinium bromide) was 
purchased from Sigma-Aldrich® (Saint-Quentin Fallavier, France), CAS 101-26-8. The 
solution was stocked at a concentration of 0.01mol/L into physiological saline. The stock 
solution was then dissolved at 1.65mg/kg into saline solution. 
-Eucalyptol (1,8-cineaole), a TRPM8 (transient receptor potential cation channel subfamily M 
member 8) agonist involved in the sensory system and in mediating analgesia, was purchased 
from Sigma-Aldrich® (Saint-Quentin Fallavier, France), CAS 470-82-6. The efficient dose 
was estimated at 300mg/kg (Ha et al., 2015). A total volume of 20µL of eucalyptol diluted in 
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corn oil was instilled intranasally, drop by drop alternatively in each nostril using a positive-
displacement pipet. Two instillations were performed: the first one 7 min before and the 
second one 13 min after subcutaneous injection of ChEIs.The duration of instillation was 
around 2 minutes. 
2.3 Double chamber plethysmography 
We used the double-chamber plethysmograph (DCP) (Emka Technologies®, Paris, France) to 
follow the ventilation (Hoymann, 2012). The plethysmograph contains two chambers: a head 
chamber and a body chamber. The mouse is placed in a conical restrainer which follows the 
animal’s head shape and ensures that there is no airflow between the two chambers. The 
conical restrainer is inserted into the body chamber. The plethysmograph has two 
pneumotachographs (pnt). These are air passages which establish a linear relationship 
between airflow and pressure difference on each side. The pressure depends on the breathing 
of the mouse. The breathing creates two distinct airflows: the nasal flow, generated by flow of 
air in and out of the nose; and the thoracic flow, generated by compression and expansion of 
air when the thorax rises and falls. The two flows are recorded in parallel at a frequency of 
2000Hz. The changes of pressure in each compartment are measured, independently of 
temperature, by a differential pressure transducer (dpt). One dpt measures the pressure 
difference between the head chamber and the atmosphere. The other dpt measures the 
pressure difference between the body chamber and the atmosphere (Fig 1A). This non-
invasive technique, used in conscious mice, avoids the need of anesthesia.  
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2.3.1 Analyzers setting 
The analyzers measure the time delay between the nasal and thoracic flow that depends on 
airway resistance. Each analyzer is tuned as follow: 
- flow threshold: 0.15mL/s 
- measure RT at: 30% of tidal volume (TV) 
- start inspiration interpolate from: 5% peak inspiratory flow (PIF) 
- compute breathing rate from: peak expiration flow (PEF) to peak inspiratory flow (PIF) 
- end inspiratory pause (EIP): interpolation of 60% PEF 
- end expiratory pause (EEP): interpolation of 30% PEF 
2.3.2 Recording 
Naïve mice were inserted in the tube 5 minutes before recording to acclimate them to the 
device. The physiological breathing was recorded over 15 minutes as an internal control. 
Then, the mouse was taken out of the DCP. Depending on its group, the mouse received a 
subcutaneous injection and/or a nasal instillation of the compounds. Then, the breathing was 
recorded for 35 minutes. The clinical symptoms of poisoning were only visible when the 
mouse came out of the tube. They were thus noted at the end of each experiment. The mice 
which had been challenged with toxic compounds were euthanized by an overdose of 
pentobarbital dissolved into saline solution. 
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2.4 Data analysis 
2.4.1 Groups of mice 
The mice strains have been challenged randomly with toxic compounds. Distribution of mice 
in terms of body weight, age and number in each group combining strain and compound is 
detailed in table S1.  
2.4.2 Parameters setting 
The raw data of the breathing were visualized and analyzed manually using LabChart Pro 
V8® (ADInstruments©, Paris, France) and automatically by Iox® (Emka Technologies 
software®, Paris, France). In LabChart the peak inspiratory flow was selected to define the 
beginning of each breathing cycle since it was an easy and reliable parameter. We calculated, 
for each cycle, the other parameters for the nasal and thoracic flow: respiratory frequency, 
tidal volume, peak inspiratory flow, peak expiratory flow and amplitude. Each parameter was 
averaged over a window of 5 seconds, selected approximately every 20 seconds. In Iox®, 
inspiratory time, expiratory time, end inspiratory pause, end expiratory pause, time delay, 
specific airway resistance and volume minute were determined automatically for each cycle. 
They were determined as illustrated in supplementary figure:  
-Ti (time of inspiration) started at the intersection of the straight line defined by the point 5% 
and 10% of PIF and the line of flow 0 and finished at the intersection of the straight line 
defined by the point 10% and 5% of PIF and the line of flow 0. AC
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-EIP (End inspiratory pause) were included into Te. EIP started at the end of the inspiration 
period and ended at the intersection of the straight line defined by the point 40% and 80% of 
PEF and the line of flow 0.  
-sRAW (specific airways resistance) was calculated according to a mathematical formula 
previously described (Pennock et al., 1979). 
2.4.3 Intra-group comparison  
Data were evaluated using OriginPro® (OriginLab, Northampton, MA). All parameters 
obtained with LabChart Pro V8® or Iox® were represented over time for each mouse. We 
compared the recorded parameters of breathing between 0 and 14min30s (corresponding to 
physiological breathing, called “before” in figures) (n=±30 sequences per mouse) and the 
ones recorded between 28 and 45min or 33 and 50min (corresponding to altered breathing 
called “after” in figures) (n±60 sequences per mouse) depending on the time of injection (15 
or 20min respectively after the introduction of both mice in their restrainer).  
We obtained, for each parameter, the mean value ± standard deviation for each mouse, before 
and after injection of the compound. To filter the values given by Iox® due to the mouse 
moving or signal distortion, we selected Iox® data according to the mean of respiratory 
frequency ± standard deviation obtained and validated by selection of raw data in Labchart® 
(the sequence of 5 seconds was validated if and only if the respiratory frequency of the thorax 
was equal of the respiratory frequency of the nasal ±0.5 Hz) 
To compare each parameter, we used a paired sample t-Test of the mean values between the 
physiological (before injection) and the altered (after injection) breathing. In the figures, data 
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(respiratory frequency, Ti, EIP and sRAW) were represented in box charts (with percentiles 25 
and 75). P-values of less than 0.05 were considered as significant.  
2.4.4 Inter-group comparison 
Data were evaluated using OriginPro® software. All parameters obtained, with LabChart® or 
Iox®, were represented over time for each mouse. According to the administered compound 
or the genetic background of the mouse, the recorded parameters of breathing between 28 and 
45min or 33 and 50min (altered breathing=after) (n±60 per mouse), depending on the time of 
injection (15 or 20min), were compared using a one-way ANOVA followed by Tukey 
posthoc test. We chose to represent the absolute value and the percentage of the variation of 
each parameter from their physiological value. In the figures, data (respiratory frequency, Ti, 
EIP and sRAW) were represented in box charts (with percentiles 25 and 75). P-values of less 
than 0.05 were considered as significant. 
Statistical analysis was done, on the mean value (intra and inter-group) of each parameter and 
as well as on the percentage of variation (inter-group) of each parameter. The latter value 
allowed determining the trend of the variation before and after injection of compound and to 
compare the value between groups. However, EIP has not been represented in percentage of 
variation because its values before injection was less than 1ms; which implied that the 
variations of the values for these data were too heterogeneous and could not be used to draw 
any meaningful conclusion.  
The variation of the volume exchanged has been observed on the absolute mean values. 
The mean value of some parameters (Fq, Ti, Te, EIP, EEP, RT, MV: the volume of gas 
inhaled (inhaled minute volume) and exhaled (exhaled minute volume) from the lungs of a 
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mouse per minute were also represented for each group in order to compare the evolution of 
breathing over time. 
3 Results 
3.1 At rest, mice with a severe deficit of synaptic AChE breathed almost normally  
Double chamber plethysmography is a sensitive method to simultaneously quantify the flow 
of air that passes through the nose and the flow of air moved by the thorax during the 
breathing cycle (Fig 1A). We have compared the breathing ventilation of WT mice with that 
of the mice in which AChE is not anchored on CNS cholinergic neurons (PRiMA KO mice) 
or absent at the NMJ (AChE1iRR and Colq KO mice). A representative example of the 
airflow is presented in (Fig 1B) for WT and mutant mice. WT mice breathed with an average 
respiratory frequency of 304±27 cycles per minute (cpm). There was no significant difference 
between WT mice and mutant mice: the mean respiratory frequency of PRiMA KO mice was 
303±57cpm (p>0.05), that of AChE1iRR mice was 296±59cpm (p>0.05), and that of Colq 
KO mice was 248±37cpm (p>0.05). Other parameters like the inspiratory time, the expiratory 
time and the thoracic tidal volume were similar in the four mouse strains (Fig 1C and S2 
Table). The Colq KO mice differed from the other mice strains by the higher specific airway 
resistance (5.3±1cm H2O.s) than in WT (4.0±0.5cm H2O.s, p<0.05) and in PRiMA KO 
(3.8±1cm H2O.s, p<0.01) mice. The mice with AChE deficits at the NMJ tend to have an 
affected pattern (dynamic of airflow during inspiration phase), but that it did not affect the 
basic physiology of breathing, indicating adequate adaptation of cholinergic synapses in the 
muscles. Despite the fine control of airflow was changed in mice with AChE deficit at the 
NMJ, we did not observe any major difference of breathing parameters between the mutant 
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mice and the WT mice (S2 Table). We concluded that all the mutant mice adapt remarkably 
to the deficit of AChE in cholinergic synapses of CNS or skeletal muscles. 
3.2 In WT mice both paraoxon and physostigmine changed breathing pattern 
more severely than pyridostigmine 
In WT mice, acute intoxications with 0.4mg/kg of paraoxon or 0.27mg/kg of physostigmine 
both dramatically changed their breathing pattern (Fig 2A and 2B). The respiratory frequency 
decreased by 64% (295±41cpm to 112±85cpm, p<0.01) after paraoxon and by 78% 
(283±42cpm to 61±16cpm, p<0.01) after physostigmine. The decrease of the respiratory 
frequency was similar between both groups (p>0.05). The mean values of the respiratory 
frequency were both significantly lower than those of the control group injected with vehicle 
(p<0.01 for both paraoxon and physostigmine) (Fig 2C). The frequency reduction was partly 
due to a significant increase in inspiratory time (72%: from 97±11ms to 169±55ms, p<0.01 
for paraoxon and 97% from 103±16ms to 200±17ms, p<0.01 for physostigmine) but mainly 
due to an increase of 430% in the expiratory time (112±15ms to 617±339ms, p<0.01) after 
paraoxon and by 668% (114±22ms to 863±292ms, p<0.01) after physostigmine. The increase 
of the inspiratory and expiratory time was similar in each group (p>0.05 for both) whereas the 
mean values of the inspiratory and expiratory time were significantly higher than those of the 
group injected with vehicle (p<0.01 for both paraoxon and physostigmine) (S2 Table). The 
increase of expiratory time (data not shown) was mostly due to the appearance of EIP of 
variable duration: from 3±2ms to 322±225ms (p<0.01) after paraoxon and from 15±9ms to 
672±265ms, (p<0.01) after physostigmine. EIP after physostigmine were longer than the ones 
obtained after paraoxon (p<0.01) (Fig 2C). The specific airways resistance was increased after 
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pyridostigmine poisoning compared to vehicle (p<0.001), paraoxon (p<0,01) and 
physostigmine (p<0,01) injection. 
A classical pharmacological strategy to distinguish central versus peripheral action of ChEIs 
is to compare the action of membrane permeant inhibitors, like physostigmine, with the action 
of charged inhibitors like pyridostigmine that cannot cross the BBB and therefore cannot 
reach the brain ChEs. We thus exposed WT mice to pyridostigmine. Mice treated with a sub-
lethal dose of pyridostigmine (1.65mg/kg) presented smaller alterations of breathing than WT 
mice exposed to physostigmine (Fig 2). The respiratory frequency was decreased but less than 
with physostigmine (p<0.01) and there were no EIP (p>0.05). The resistance of airways was 
increased by 82% (3.8±0.7 to 6.8±1.2cm H2O.s, p<0.01) (S2 Table). The profile of ventilation 
after pyridostigmine exposure is thus significantly different than that observed with 
physostigmine or paraoxon.  
3.3 PRiMA KO mice have more similar sensitivity to physostigmine and 
pyridostigmine than WT mice 
To explore if the difference of response to physostigmine and pyridostigmine resulted from 
the selective inhibition of brain AChE by physostigmine, we exposed PRiMA KO mice that 
are adapted to the absence of central AChE and to the resulting high level of ACh in CNS 
(Farar et al., 2012). We expected that physostigmine would only minimally change the 
respiration in PRiMA KO mice, and would mimic the effects of pyridostigmine on WT mice. 
However, as illustrated (Fig 3A and 3B), the respiration of PRiMA KO mice was significantly 
changed by physostigmine or pyridostigmine and presented a similar reduction of respiratory 
frequency (p>0.05): from 303±48cpm to 132±35cpm, (p<0.01) for physostigmine and from 
310±60cpm to 171±24cpm, (p<0.01) for pyridostigmine (Fig 3B). Physostigmine and 
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pyridostigmine both induced a similar increase of Ti (p>0.05) (Fig 3C). As in WT mice, 
pyridostigmine triggered only very short EIP (5±6ms to 38±25ms, p=0.025). Physostigmine 
triggered EIP (12±10ms to 156±136ms, p<0.05) (Fig 3C). Despite the differences in the 
induction of EIP, pyridostigmine and physostigmine produced significant respiratory effects 
in PRiMA KO mice which have no AChE in the central cholinergic synapses. These effects 
must therefore have involved the inhibition of peripheral ChEs. 
3.4 The depression of ventilation by physostigmine is reduced in Colq KO mice, 
which have a normal level of AChE in brain  
If AChE inhibited by physostigmine in the respiratory center is the main cause of the long EIP 
in WT mice, we expected the occurrence of long pauses in exposed Colq KO mice in which 
AChE was normally expressed in the brain. To test this hypothesis, we exposed Colq KO 
mice to physostigmine (Fig 4A and 4B). The respiratory frequency decreased by 52±10% 
(p<0.01), a decrease which was significant but smaller (p<0.01) than that induced by 
physostigmine in WT mice which was decreased by 79±5% (p<0.01) (Fig 4C). Ti increased 
by 31±23% (p<0.01) in Colq KO mice, much less than in WT mice (97±26%, p<0.01). More 
importantly, EIP duration increased 10-fold less in Colq KO mice (64±39ms, p<0.05) than in 
WT mice (672±265ms, p<0.01) (Fig 4C). The specific airways resistance, which was higher 
in control Colq KO mice than in control WT mice (p<0.05), was not changed by 
physostigmine (p>0.05). These results supported that the duration of EIP depends 
significantly on ChE inhibition in peripheral tissues. 
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3.5 AChE1iRR mice, that do not produce AChE in skeletal muscles react similarly 
to physostigmine and pyridostigmine  
The fact that Colq KO mice were less sensitive to physostigmine than WT mice suggested 
that the AChE anchored in the NMJ plays a major role in the respiratory failure induced by 
ChE inhibitors. To further confirm the importance of AChE in skeletal muscles, we examined 
the breathing of AChE1iRR mice. Despite adapations of the skeletal muscles to the absence 
of AChE, AChE1iRR mice remained sensitive to physostigmine or pyridostigmine (Fig 5A 
and 5B). After physostigmine or pyridostigmine injection, the respiratory frequency of these 
mice decreased respectively by 66±17% (p<0.01) and by 44±11% (p<0.01) and Te increased 
respectively by 395±237% (p<0.01) and by 119±50% (p<0.01). We observed an increase of 
EIP durations after physostigmine poisoning (21±15ms to 150±77ms, p<0.01). As in WT 
mice; EIP durations increase slightly after pyridostigmine injection (10±7ms to 40±22ms, 
p<0.01). The airways resistance increased respectively by 26±23% (p<0.05) and by 59±35% 
(p<0.01) (Fig 5C).  
3.6 Eucalyptol shortens the long end inspiratory pause triggered by physostigmine 
EIP are stereotyped responses when mice breathe irritant molecules (Dutschmann et al., 
2014). Moreover, the duration of EIP triggered by irritant molecules (e.g. acrolein, 
cyclohexanone, etc) acting on afferent sensory neuron was reduced by menthol or eucalyptol 
through the activation of TRPM8 (cold and menthol receptor 1) located in afferent neurons 
(Ha et al., 2015). If EIP triggered by physostigmine have a similar origin (activation of 
afferent sensory neurons), the duration of EIP could be shortened by eucalyptol. AC
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Eucalyptol instilled alone did not change overall breathing parameters (data not shown). 
Instillations of eucalyptol before and after injection of physostigmine reduced the duration of 
EIP by 10-fold from 672±265ms (without eucalyptol) to 67±50ms (with eucalyptol) (p<0.01) 
(Fig 6C). However, eucalyptol treatment slightly rescued the respiratory frequency decreased 
provoked by physostigmine poisoning (p<0.05) and did not reduce Ti (S2 Table). The 
instillation of eucalyptol increased the airways resistance. Indeed, sRAW value of the group 
treated with eucalyptol alone increased by 9% (3.7±0.3 to 3.9±0.2cm H2O.s, p<0.05). It was 
exacerbated (p<0.01) in mice exposed to physostigmine and treated by eucalyptol, with a 
significant increase of 122% (3.5±0.4 to 8.0±3.7cm H2O.s, p<0.01) compared to the group 
with physostigmine alone, which did not present any increase of sRAW (3.9±1.3 to 4.9±1.2cm 
H2O.s, p>0.05) (Fig 6C).  
4 Discussion 
The respiratory failures triggered by OPs are multifactorial due to the fact that these very 
reactive molecules bind diverse proteins in addition to ChE. However, it strikingly resembles 
the syndrome induced by carbamate pesticides (Hulse et al., 2014), which are more selective 
inhibitors of ChEs. One can thus assume that ChE inhibition is responsible for the respiratory 
failure for both classes of compounds. ChEs are present both in the CNS and in the peripheral 
nervous system (PNS). We have taken advantage of mice in which AChE is absent in the 
synapses either in the CNS or in the PNS to evaluate the relative contributions of the 
inhibition of central and peripheral ChEs to specific respiratory pauses, the pause after 
inspiration that were specifically triggered by physostigmine and paraoxon but not by 
pyridostigmine. We exposed mice to ChEIs in which AChE is either not anchored in 
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cholinergic synapses in the CNS (PRiMA KO mice) or absent at the NMJ (Colq KO or 
AChE1iRR mice). Except the highest specific resistance of Colq KO mice which could be 
explained by the sever growth retardation and muscle weakness of these mice (Bernard et al., 
2011; Feng et al., 1999), it is worth noting that all these mice are adapted to the excess of 
ACh on synaptic ACh receptors and physiologically breathe like WT mice (Fig 1). One can 
thus assume that, due to the lack of their target in the synapses, ChEIs should not affect the 
synaptic transmission in the CNS of PRiMA KO mice, and conversely that they should not 
alter the functioning of the NMJ in Colq KO or AChE1iRR mice. The results obtained allow 
three main conclusions: 
4.1 The respiratory failure induced by ChEIs involves both central and peripheral 
cholinesterases  
When intoxicated with physostigmine, a ChEI that crosses the BBB and therefore acts on both 
central and peripheral AChE, mutant mice showed a depression of breathing. But in all cases 
these effects were less marked than in WT mice (Fig 2, 3, 4 and 5). These results support the 
canonical hypothesis that the respiratory modifications of WT mice involve inhibition of 
ChEs at both central and peripheral cholinergic synapses. Different doses of physostigmine 
may help to reveal more effects triggered by ACh. 
Among the different changes, the appearance of long “end inspiratory pause” (EIP) accounted 
for a large part of the reduced frequency in our conditions of exposure to physostigmine or 
paraoxon. These pauses were almost absent in Colq KO mice in which AChE is normal in 
CNS. This suggests that the duration of EIP requires the inhibition of peripheral AChE at the 
NMJ but not in the brain. The duration of these pauses was reduced after physostigmine 
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poisoning in PRiMA KO and AChE1iRR mice. The differences between AChE1iRR and 
Colq KO mice support that the duration of EIP is not simply due to the modification of the 
synaptic transmission at the NMJ that is similarly affected in these mice. In fact, Colq is 
associated with AChE in several tissues in addition to the skeletal muscles (Taxi and Rieger, 
1986), and thus these tissues were probably adapted to AChE deficit in Colq KO but not in 
AChE1iRR mice. It is also relevant to note that PRiMA anchors AChE and BChE in almost 
all the peripheral tissues in addition to brain and thus the shorter duration of EIP induced by 
physostigmine in PRiMA KO mice can be related to the adaptation of peripheral tissues to 
ChE deficit. Altogether, these results suggest that the long EIP triggered by physostigmine 
result from the inhibition of cholinesterase in peripheral tissues. 
4.2 The end inspiratory pauses which were observed in most exposure may be 
triggered by activation of afferent pathways  
Pauses after inspiration are normal reflexes of mice and are essential to adapt the airflow to 
the orofacial behavior (i.e. protection of airways, cough swallowing, vocalization…) 
(Dutschmann et al., 2014; Moore et al., 2014). When mice breathe irritant molecules such as 
acrolein or cyclohexanone, molecules found in cigarette smoke, long EIP appear in minute. 
The duration of these pauses is reduced when the mouse breathes simultaneously the irritant 
molecules and eucalyptol, an agonist of TRMP8, the cold sensitive receptor (Willis et al., 
2011). The fact that the long EIP triggered by physostigmine were also reversed by 
eucalyptol, a counterirritant molecule, suggests that the sensory system is involved in the 
response to inhibition of ChE.. In airways, non-neuronal ACh has multiple functions and may 
thus directly or indirectly activate afferent sensory neurons (Kummer and Krasteva-Christ, 
2014). Our results thus suggest that the loss of central respiratory drive previously described 
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during OP exposure (Klein-Rodewald et al., 2011) could be triggered by a direct or indirect 
action of ACh on afferent sensory neurons in addition to the modifications of cholinergic 
synaptic transmission in the respiratory centers and at the NMJ. 
4.3 Spillover of ACh after inhibition of ChEs could be a major source in the 
activation of the reflex EIP and exaggerates function of non-neuronal ACh 
In our experimental conditions, EIP duration depends on AChE at the NMJ but not directly 
from the synaptic transmission at the NMJ, and depends on the action of ACh in airways. To 
link these two observations, we propose that, in addition to the well-known control of the 
synaptic transmission, a critical function of AChE at the NMJ and presumably in other 
cholinergic synapses is to prevent the spillover of ACh (Katz and Miledi, 1975). At synaptic 
level, the spillover of ACh was already described in central cholinergic synapses (Lamotte 
D’Incamps et al., 2012) and at the NMJ (Petrov et al., 2014) and AChE and BChE seemed 
both implied in ACh confinement at the synaptic cleft (Petrov et al., 2014). Rats challenged 
with OPs showed a consecutive flood of ACh in the blood (Stewart, 1952) that may activate 
distant targets. Thus, the toxicity of ACh would appear when the spillover of ACh from 
neuron (mainly NMJ) may reach sites where low quantity of ACh, secreted by non-neuronal 
cells, is used to modulate physiological functions (e.g. inflammation, heart rate, sensory 
reflexes, etc.) (Grando et al., 2015; Tracey, 2016).  
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5 Conclusion 
The ventilation of mice exposed to ChE inhibitors was strongly altered. We quantified the 
duration of pauses after inspiration and found 1) the duration of the pauses depends on AChE 
inhibition at the NMJ and 2) these pauses are reversed by eucalyptol, a counterirritant 
molecule which suggests that ACh may act as an irritant molecule on sensory system. We 
propose that physiological hydrolysis of ACh by AChE at the NMJ prevents ACh spillover 
from the NMJ. Such spillover of ACh when ChEs are inhibited could be critical to ventilation 
because ACh may activate sensory neurons and trigger reflexes dedicated to respiratory tract 
protection. 
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Legends 
 
Fig 1.  Physiological breathing ventilation of mice with severe deficit in ChE. 
(A) Schematic presentation of the double chamber plethysmography device; pnt 
(pneumotachographs) dpt (differential pressure transducer) (upper part). The nasal (left) and 
thoracic (right) airflow recorded, opposite nasal signal and thoracic signal have been overlaid 
in the central diagram (inspiration downward in yellow strip, expiration upward in purple 
strip) (lower part). (B) Representative example of thorax flow recorded (10 seconds): WT 
(orange), PRiMA KO (violet), AChE1iRR (olive) and Colq KO (green) mice at least 13min 
after a subcutaneous injection of vehicle (DMSO diluted into saline solution). (C) The 
respiratory frequency, the inspiratory time, the expiratory time and the specific airways 
resistance of breathing of four strains of mice (WT, PRiMA KO, AChE1iRR and Colq KO 
mice) are represented in box charts (with percentile 25 and 75). Statistical comparisons (one 
way ANOVA followed by Tukey posthoc test) were carried out between WT (orange, n=8), 
PRiMA KO (violet, n=8), AChE1iRR (olive, n=8) and Colq KO (green, n=8) mice. P-values 
of less than 0.05 were considered as significant (* for p<0.05, ** for p<0.01, *** for 
p<0.001). 
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Fig 2. Impairment of ventilation of WT mice after administration of paraoxon, 
physostigmine or pyridostigmine. 
(A) Representative examples of breathing pattern of WT mouse, the thoracic flow before 
injection (grey line) was overlaid by the thoracic flow after subcutaneous injection of vehicle 
(orange line) or paraoxon (green line) or physostigmine (blue line) or pyridostigmine (red 
line). (B) Time course of respiratory frequency (cpm) (right) and duration of end inspiratory 
pause (ms) (left) of WT mice before (yellow zone) and after subcutaneous injection of vehicle 
(orange, n=8), paraoxon (green, n=8), physostigmine (blue, n=8) or pyridostigmine (red, 
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n=8). Data are represented as the 1 minute mean±SD. (C) Statistical comparisons (one-way 
ANOVA followed by Tukey posthoc test) on the respiratory frequency, the inspiratory time, 
the end inspiratory pause and the specific airways resistance of breathing of WT mice were 
carried out between control group (orange, n=8), paraoxon (green, n=8), physostigmine (blue, 
n=8) and pyridostigmine (red, n=8). Data are expressed in percentage of variation compared 
to the same parameters before injection, or mean value after injection. Data are represented in 
box charts (with percentile 25 and 75). P-values of less than 0.05 were considered as 
significant (* for p<0.05, ** for p<0.01, *** for p<0.001). 
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Fig 3. Impairment of ventilation of PRiMA KO mice after administration of 
physostigmine or pyridostigmine. 
(A) Representative example of breathing pattern of a PRiMA KO mouse, the thoracic flow 
before injection (grey) was overlaid by the thoracic flow after subcutaneous injection of 
vehicle (orange) or physostigmine (blue) or pyridostigmine (red). (B) Time course of 
respiratory frequency (cpm) (right) and duration of end inspiratory pause (ms) (left) of 
PRiMA KO mice before (yellow zone) and after subcutaneous injection of vehicle (orange, 
n=8), physostigmine (blue, n=8) or pyridostigmine (red, n=9) (left). Data are represented as 
the 1 minute mean±SD. (C) Statistical comparisons (one way ANOVA followed by Tukey 
posthoc test) on the respiratory frequency, the inspiratory time, the end inspiratory pauses and 
the specific airways resistance of breathing of PRiMA KO mice were carried out between 
control group (orange, n=8), physostigmine (blue, n=8) and pyridostigmine (red). Data are 
expressed in percentage of variation compared to the same parameters before injection, or 
mean value after injection. Data are represented in box charts (with percentile 25 and 75). P-
values of less than 0.05 were considered as significant (* for p<0.05, ** for p<0.01, *** for 
p<0.001). 
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Fig 4. Deficit of AChE at the NMJ prevents acute depression of respiration by 
physostigmine.  
(A) Representative example of breathing pattern Colq KO mice, the thoracic flow before 
injection (grey) was overlaid by the thoracic flow after subcutaneous injection of 
physostigmine (blue). (B) Time course of respiratory frequency (cpm) (right) and duration of 
end inspiratory pause (ms) (left) of WT (grey, n=8) and Colq KO (green, n=8) mice before 
(yellow zone) and after subcutaneous injection of physostigmine. Data are represented as the 
1 minute mean±SD. (C) Statistical comparisons (one way ANOVA followed by Tukey 
posthoc test) on the respiratory frequency, the inspiratory time, the end inspiratory pauses and 
the specific airways resistance of breathing were carried out between WT (grey, n=8) and 
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Colq KO (green, n=8) mice. Data are expressed in percentage of variation compared to the 
same parameters before injection, or mean value after injection. Data are represented in box 
charts (with percentile 25 and 75). P-values of less than 0.05 were considered as significant (* 
for p<0.05, ** for p<0.01, *** for p<0.001). 
 
Fig 5. Impairment of ventilation of AChE1iRR mice after administration of 
physostigmine or pyridostigmine.  
(A) Representative example of breathing pattern of a AChE1iRR mouse, the thoracic flow 
before injection (grey) was overlaid by the thoracic flow after subcutaneous injection of 
vehicle (orange) or physostigmine (blue) or pyridostigmine (red). (B) Time course of 
respiratory frequency (cpm) (right) and duration of end inspiratory pause (ms) (left) of 
PRiMA KO mice before (yellow zone) and after subcutaneous injection of vehicle (orange, 
n=8), physostigmine (blue, n=8) or pyridostigmine (red, n=9) (left). Data are represented as 
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the 1 minute mean±SD. (C) Statistical comparisons (one way ANOVA followed by Tukey 
posthoc test) on the respiratory frequency, the inspiratory time, the end inspiratory pauses and 
the specific airways resistance of breathing of AChE1iRR mice were carried out between 
control group (orange), physostigmine (blue) and pyridostigmine (red). Data are expressed in 
percentage of variation compared to the same parameters before injection, or mean value after 
injection. Data are represented in box charts (with percentile 25 and 75). P-values of less than 
0.05 were considered as significant (* for p<0.05, ** for p<0.01, *** for p<0.001). 
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Fig 6. Eucalyptol reversed the long pause triggered by physostigmine in WT 
mice.  
(A) Representative examples of breathing patterns. The thoracic flow before injection or 
instillation was presented as grey line. Left pattern, the thoracic flow after two instillations of 
eucalyptol alone was presented. Right patterns the thoracic flow after subcutaneous injection 
of physostigmine alone (blue line) or treated by eucalyptol instillations (green line). (B) Time 
course of respiratory frequency (cpm) (right) and duration of end inspiratory pause (ms) (left) 
before (yellow zone) and after subcutaneous injection of physostigmine (blue, n=8) and 
physostigmine + eucalyptol treatments (green, n=8). Data are represented as the 1 minute 
mean±SD. Eucalyptol has been instilled twice as noted by green arrows. (C) Statistical 
comparisons (one way ANOVA followed by Tukey posthoc test) on the respiratory 
frequency, the inspiratory time, the end inspiratory pauses and the specific airways resistance 
of breathing of WT mice were carried out between control group (grey, n=8), eucalyptol alone 
(green, n=5), physostigmine alone (blue, n=8) and physostigmine + eucalyptol treatment 
(green, n=8). Data are expressed in percentage of variation compared to the same parameters 
before injection, or mean value after injection. Data are represented in box charts (with 
percentile 25 and 75).. P-values of less than 0.05 were considered as significant (* for p<0.05, 
** for p<0.01, *** for p<0.001).  
AC
CE
PT
ED
 M
AN
US
CR
IPT
 34 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
